WPA
MDLN

West Paces Advisors’s Medline Inc MDLN Stock Holding History

West Paces Advisors’s Portfolio MDLN Stock Details MDLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$276 Buy
+7
New +$282 ﹤0.01% 730

Other funds holding MDLN

ECU
Egerton Capital (UK) London, United Kingdom $10.4B AUM 25.66% 1-Year Est. Return
BPC
Banque Pictet & Cie Geneva 73, Switzerland $16B AUM 29.1% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $81.4B AUM 40.71% 1-Year Est. Return
MIF
Mediolanum International Funds Dublin 1, Ireland $11.7B AUM 47.18% 1-Year Est. Return
BPCE
Bank Pictet & Cie (Europe) Frankfurt Am Main, Germany $5.12B AUM 27.39% 1-Year Est. Return
PFM
Premier Fund Managers Guildford, United Kingdom $1.1B AUM 14.42% 1-Year Est. Return
CAM
Clio Asset Management Charlottesville, Virginia $126M AUM 16.01% 1-Year Est. Return
FAMI
Fideuram Asset Management (Ireland) Dublin 1 $5.26B AUM
PBT
Pictet Bank & Trust Nassau, Bahamas $93.3M AUM 21% 1-Year Est. Return
II
IFM Investors Melbourne, Australia $15.1B AUM 40.57% 1-Year Est. Return

West Paces Advisors's MDLN Position: Q2 2026 in Review

West Paces Advisors opened a new position in Medline Inc (MDLN) in Q2 2026: 7 shares worth $276. The stake represents ﹤0.01% of the portfolio and ranks #730 among its holdings.

59 funds tracked by Wall St. Rank hold MDLN as of Q2 2026.

  • West Paces Advisors held 7 shares of Medline Inc worth $276 as of Q2 2026.
  • Medline Inc was a new West Paces Advisors position in Q2 2026.
  • Medline Inc made up ﹤0.01% of West Paces Advisors's portfolio in Q2 2026, its #730 holding.
  • 59 funds tracked by Wall St. Rank held Medline Inc as of Q2 2026.

Based on West Paces Advisors's 13F filing for Q2 2026, filed 20 Jul 2026.